학술논문

A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma

Document Type

Article

Author

D'souza, A.; Shah, N.; Rodriguez, C.; Voorhees, P.M.; Weisel, K.; Bueno, O.F.; Pothacamury, R.K.; Freise, K.J.; Yue, S.; Ross, J.A.; Polepally, A.R.; Talati, C.; Lee, S.; Jin, Z.; Buelow, B.; Vij, R.; Kumar, S.

Source

In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 1 November 2022, 40(31):3576-3586)

Subject

Language

English

ISSN

15277755
0732183X

Online Access

Full Text (ASCO/JCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송